We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. McKesson (MCK - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
McKesson is a member of the Medical sector. This group includes 916 individual stocks and currently holds a Zacks Sector Rank of #11. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. McKesson is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for MCK's full-year earnings has moved 1% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, MCK has moved about 11% on a year-to-date basis. In comparison, Medical companies have returned an average of 0.1%. This means that McKesson is performing better than its sector in terms of year-to-date returns.
Another Medical stock, which has outperformed the sector so far this year, is Avantor, Inc. (AVTR - Free Report) . The stock has returned 33.9% year-to-date.
Over the past three months, Avantor, Inc.'s consensus EPS estimate for the current year has increased 2.9%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, McKesson belongs to the Medical - Dental Supplies industry, a group that includes 14 individual stocks and currently sits at #107 in the Zacks Industry Rank. Stocks in this group have gained about 3.8% so far this year, so MCK is performing better this group in terms of year-to-date returns.
Avantor, Inc., however, belongs to the Medical Services industry. Currently, this 70-stock industry is ranked #103. The industry has moved +3.4% so far this year.
McKesson and Avantor, Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.
View the Zacks #1 Rank List
Image: Bigstock
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. McKesson (MCK - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
McKesson is a member of the Medical sector. This group includes 916 individual stocks and currently holds a Zacks Sector Rank of #11. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. McKesson is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for MCK's full-year earnings has moved 1% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, MCK has moved about 11% on a year-to-date basis. In comparison, Medical companies have returned an average of 0.1%. This means that McKesson is performing better than its sector in terms of year-to-date returns.
Another Medical stock, which has outperformed the sector so far this year, is Avantor, Inc. (AVTR - Free Report) . The stock has returned 33.9% year-to-date.
Over the past three months, Avantor, Inc.'s consensus EPS estimate for the current year has increased 2.9%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, McKesson belongs to the Medical - Dental Supplies industry, a group that includes 14 individual stocks and currently sits at #107 in the Zacks Industry Rank. Stocks in this group have gained about 3.8% so far this year, so MCK is performing better this group in terms of year-to-date returns.
Avantor, Inc., however, belongs to the Medical Services industry. Currently, this 70-stock industry is ranked #103. The industry has moved +3.4% so far this year.
McKesson and Avantor, Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.